The Grant Rulebook Is Being Rewritten: What OMB's 2 CFR Part 200 Overhaul Means for Every Federal Recipient Before October 1
July 18, 2026 · 6 min read
Granted Research Team · Editorial policy
Most grant regulation changes are invisible to the people who live under them. A threshold moves, an audit form gets renumbered, a cost category gets a new footnote, and the average recipient never notices. The rule OMB published on May 29, 2026 is not that kind of change. Titled simply "Regulation for Federal Financial Assistance," it is the most sweeping rewrite of 2 CFR Part 200 — the Uniform Guidance that governs how nearly every federal grant dollar in America is awarded, spent, and closed out — since the framework was consolidated in 2013. It rewrites the terms under which universities, nonprofits, cities, counties, states, tribes, and research institutions accept federal money. And it does so on a compressed clock: a 45-day comment period that closed July 13, 2026, and a proposed effective date of October 1, 2026 — the first day of FY2027.
The public noticed. The docket, OMB-2026-0034, drew close to half a million comments — a volume that puts it in the same league as the most contested rulemakings in modern federal history. That reaction is not about paperwork. It is about who decides what gets funded, and whether an award you already hold is safe. This is the definitive breakdown of what the rule actually does, section by section, and what recipients should be doing between now and October 1. For the short version of the news, see our Granted News brief; what follows is the deep analysis.
The three changes that matter most
Strip away the framing language and three structural shifts carry almost all the weight.
1. Political pre-issuance review of every discretionary grant (§ 200.205). Under the proposal, a senior political appointee must review every discretionary award before it is issued and confirm that it "demonstrably advances the President's policy priorities." Peer review — the merit-based scientific and technical evaluation that has anchored agencies like NIH and NSF for decades — is explicitly downgraded to advisory. Reviewing officials are instructed to exercise "independent judgment" and are told they may not "routinely defer" to expert panels. In plain terms: the expert score becomes a recommendation, and a political appointee holds the pen.
2. Termination "in the interest of the federal agency" (§ 200.340). This is the provision that has grantees most alarmed, and for good reason. Today, an agency generally needs a finding of noncompliance to end an award early. The proposed rule adds a new basis: an agency may terminate whenever doing so is "in the interest of the federal agency" or when the award "no longer effectuates program goals, agency priorities, or the national interest" — even if the recipient is in full compliance. The notice standard is minimal: a "brief summary of the reason," with no requirement for "detailed or exhaustive analysis." Critically, discretionary terminations carry no hearing or appeal rights — those procedural protections survive only for noncompliance-based terminations. A companion provision (§ 200.340(e)) adds a new 90-day suspension/stop-work authority. This mirrors the "termination for convenience" clause long familiar from federal procurement contracts — but importing it into grants rewrites the basic bargain of a multi-year award.
3. Cross-cutting policy prohibitions baked into every award. New §§ 200.218, 200.220, and 200.300 write a set of policy restrictions directly into the terms and conditions of federal funding. Awards may not "fund, promote, encourage, subsidize, or facilitate" DEI practices that violate federal anti-discrimination law, "gender ideology" activities, or gender-transition care for persons under 19. Federal funds — including indirect cost recoveries — may not support collaboration with "covered foreign countries or entities" (China, Russia, Iran, North Korea, Cuba, Venezuela, and designated entities) without express statutory authorization. And funds may not support "theories of disparate-impact liability," including related studies and litigation. A violation is defined as a "material breach" — which loops directly back to the expanded termination authority.
The quieter changes that will still cost you
The headline provisions have overshadowed a set of operational changes that will hit finance and compliance offices immediately:
- Publications (§ 200.461): unallowable unless statutorily required or approved case-by-case.
- Conferences (§ 200.432): require express agency approval.
- Advertising and public relations (§ 200.421): generally unallowable outside procurement-related purposes.
- Memberships (§ 200.454): require prior approval; journal subscriptions prohibited entirely.
- Lobbying (§ 200.450): expanded to sweep in voter registration and state-level issue advocacy unrelated to the award.
- E-Verify (§ 200.303(f)): now required for all recipients and their employees and contractors — not just federal contractors.
- Payment justification (§ 200.305): each drawdown must carry a written description tying the payment to specific activities or milestones, and pass-through entities must route payments through Treasury's Do Not Pay system.
- Fixed-amount awards (§§ 200.201–200.202): effectively eliminated unless statutorily authorized, pushing recipients back toward cost-reimbursement accounting.
- Fraud disclosure: credible evidence of fraud must be transmitted to the U.S. Attorney's Office within 10 days.
One thing the rule pointedly does not touch: indirect cost rate negotiation. OMB notes that FY2026 appropriations language bars changes there, so negotiated F&A rates stand — for now. But the rule still expresses an explicit preference for awarding grants to institutions with lower indirect cost rates, and restricts indirect recovery on the newly prohibited categories. The pressure is being applied through selection rather than through the rate itself.
Who is exposed — and who is partly shielded
The reach is broad: any organization accepting federal financial assistance — nonprofits, higher education, research institutions, state and local governments, tribes, and selected corporations. But exposure is uneven.
Research universities and academic medical centers are the most exposed. Peer review going advisory strikes at the core of how their funding is allocated, and the foreign-collaboration bans can disrupt multi-site international clinical trials. This is not hypothetical: NIH has already recorded roughly a 34% drop in new awards in 2026, driven by new layers of political review at NIH, HHS, OMB, and the Office of Extramural Research — a preview of what codifying pre-issuance review could institutionalize.
Nonprofits face the cost-principle squeeze most acutely — publications, conferences, memberships, and advocacy-adjacent activities are exactly where mission work and allowable costs blur, and the DEI and disparate-impact language reaches program design itself.
States, counties, and cities get partial cover. The expanded termination authority carves out block grants, statutory formula awards, disaster recovery grants, and awards under international trade agreements, the CHIPS Act, and the Infrastructure Investment and Jobs Act. That protects a large share of the money that flows through local governments — but discretionary competitive grants remain fully exposed, and pass-through entities inherit new burdens: strengthened SAM.gov subaward reporting, subrecipient monitoring for the new policy prohibitions, and viewpoint-neutrality requirements for events held on their property.
What to do before October 1
The rule is proposed, not final, and the comment record is enormous — some provisions may soften. But planning around the current text is the only prudent posture, because the effective date lands on new FY2027 awards and incremental funding.
- Map your portfolio against the exposure tiers. Separate formula and disaster awards (largely shielded) from discretionary and research awards (fully exposed). Your risk concentration is in the second bucket.
- Build financial separation now. Establish clean accounting boundaries between federally funded and other activities so a prohibited-cost question about one program cannot contaminate a draw on another.
- Audit international partnerships for any "covered" entity involvement, including subawards and indirect-cost-funded collaborations, and identify where statutory authorization exists.
- Re-underwrite multi-year budgets for termination risk. With "convenience" terminations on the table and no appeal, treat out-year funding as contingent. Avoid committing hires or facilities against dollars an agency can pull with a brief note.
- Stand up E-Verify and payment-justification workflows ahead of October 1 — these are operational lifts that take weeks, not days.
- Read your terms and conditions on every new award issued on or after October 1. The prohibitions become contract terms, and a "material breach" is the trigger that connects them to termination.
The Uniform Guidance was designed to make federal funding predictable — a stable rulebook that let a university or a city plan five years out. This rewrite trades predictability for discretion. Whether the final rule lands closer to the proposal or gets pulled back by the comment record, the recipients who come through cleanest will be the ones who spent the summer treating their awards as conditional and their compliance posture as the thing most within their control.
Granted tracks federal funding rules and deadlines across every agency. Search live opportunities or browse the 2026 deadline calendar to see what is open now.